Inspire hopes for diquafosol approval in 2005
Executive Summary
Inspire Pharmaceuticals says it hopes to gain approval for the dry eye agent diquafosol in 2005 pending completion of an additional clinical study required by FDA. The agency requested the study during a Jan. 29 meeting concerning a Dec. 19 "approvable" letter (1"The Pink Sheet" Jan. 5, 2004, p. 29)...